Stanley Sy is the CEO of Sanomics. He obtained his B.Eng in Electronic Engineering (Biomedical engineering) and M.Phil in Electronic Engineering (Biomedical Engineering) from The Chinese University of Hong Kong with excellent results. After graduation, he continued with his research efforts, having successfully applied for government grants while mentoring many junior researchers. In the process, he had gained valuable knowledge on patent rights while working with various stakeholders from physicians, manufacturer to patients. Prior to his current position, Stanley held the position of a Consultant for Global Business Services in IBM where he conducted business concept developments and process reviews for several industries.
His experience and expertise over the years has enabled him to be a prudent and an inspiring leader, supervise all strategic and business aspects of the company. He is appointed as a member of the Technology Voucher Programme Committee under Innovation and Technology Commission since October 2018. Same year December he is also appointed as a member under Chongqing Youth Federation Committee since.